reason report
bottom line rais pt driven
solid volum beat guidanc well ahead
consensu mm cash tax reform tailwind level
play field not-for-profit nfp competitor
announc dividend pt contempl ev
ebitda current leverag ratio beat across
board solid volum season increas acuiti even
exclud benefit flu provid guidanc
mm midpoint well ahead consensu mm
driven volum growth price well ramp
recent mm cash tax reform benefit help level play
field nfp competitor lead increas capit spend across
 continu develop altern site care off-set
acut industri pressur expect util tax tailwind
announc dividend continu share repurchas
increas adjust ebitda mm
mm respect
beat across board adjust ebitda mm
beat consensu mm driven strong season increas
flu activ revenu mm improv yoy qoq
ahead expect exhibit
bad debt ratio improv bp qoq beat expect
flat yoy self-pay chariti admiss increas
quarter note begin account chang
remov bad debt line compani continu report total
volum strong increas season flu ed
volum drove volum growth importantli
non-flu volum increas acuiti strong season
altern site offset inpati pressur drove volum bed
occup near all-tim high activ ad inpati
bed altern site care partial captur outpati shift
altern site key gain relationship patient
drive volum acut facil exhibit
price solid due stabil commerci volum
increas acuiti attribut flu commerci adjust
admiss ss commerci case mix increas
yoy ss medicar adj admiss increas ss
ev/ebitda
net debt total capit
price-to-earnings lt ep growth
estimate lt ep growth compound-annual-growth-rate
compani inform leerink partner llc research
revenu million bad debt ep present ex one-tim item
pleas refer page analyst certif import disclosur price chart disclosur specif
cover compani statement valuat risk avail
oper expens beat across board ss swb increas
plan make mm workforc invest
train educ tuition reimburs ss suppli expens
increas ss opex increas due increas
provid solid initi ebitda guidanc mm
midpoint compar consensu mm revenu ep
capit expenditur guidanc also beat consensu midpoint
maintain medium term growth target guidanc
driven volum growth price ramp recent
guidanc appear achiev strong flu season increas
season conserv hurrican impact baselin exhibit
rais estim increas adjust
ebitda mm mm compar guidanc
midpoint mm adjust ebitda increas
mm mm exhibit
mm cash tax reform tailwind help level
play field nfp competitor lead increas
 capital-expenditure increas capit expenditur program
next three year compani oper
outpati site care across urgent care free stand ed asc
imag center plan increas site
well add inpati bed remain activ
manag state pipelin remain activ exhibit
continu increas return sharehold share
repurchas new dividend announc dividend
first time also repurchas mm share
remain share repurchas author decemb
increas pt pt base
multipl revis ev/ebitda mm exhibit
rais pt reflect solid guidanc
increas capit expenditur plan like drive volum growth
announc dividend
pt contempl ev ebitda current leverag ratio
provid solid guidanc mm midpoint well consensu mm
driven volum growth price well ramp recent
increas capit expenditur outlook driven cash tax reform tailwind
increas altern site care off-set industri pressur increas hdhp shift
outpati lead volum growth beyond expect util tax
tailwind announc dividend continu share repurchas
increas adjust ebitda mm mm respect
beat across board adjust ebitda mm beat consensu
mm driven strong season increas flu activ revenu mm improv
yoy qoq ahead expect
bad debt ratio improv bp qoq beat expect flat yoy self-
pay chariti admiss increas quarter note begin
account chang remov bad debt line compani continu report total
holdingsleerinkconsensusqoqyoygross doubt debts/gross bpsnet incom net facilityrev/adj admiss bpsadmiss bpsadj admiss bpser visit bpsexpensessalaries/net bpssupplies/net bpsother expenses/net bpsreport mm except per sharereport estimatesfactset consensu healthcar inc
volum strong increas season flu ed volum meaning
increas qoq flu mainli impact decemb volum drove volum growth
importantli non-flu volum increas acuiti strong season
altern site offset inpati pressur drove volum bed occup
near all-tim high activ ad inpati bed altern site care partial
captur outpati shift altern site key gain relationship patient
drive volum acut facil
cdc npr
price solid due stabil commerci volum increas acuiti
attribut flu commerci adjust admiss ss commerci case
mix increas yoy ss medicar adj admiss increas ss medicaid
oper expens beat across board ss swb increas plan make
mm workforc invest train educ tuition reimburs ss
suppli expens increas ss opex increas due increas
provid solid initi ebitda guidanc mm midpoint compar
consensu mm revenu ep capit expenditur guidanc also beat
consensu midpoint maintain medium term growth target
guidanc driven volum growth price recent ramp guidanc
appear achiev strong flu season increas season conserv hurrican
rais estim increas adjust ebitda mm
mm compar guidanc midpoint mm adjust
ebitda increas mm mm
compani report leerink partner llc research estim note mm except bp
consensusleerinkconsensusleerinkconsensusleerinkconsensusleerinkconsensusleerinkconsensusleerinkrevenu debt expense/net opex/net rev/ per adj adj admin adjust ss top line growth bp improv bad debt normal baselin ex-hurrican mm ramp acquir asset unannounc bp improvementintern uk operationsok annual ebitda leerink ebitda inc
mm cash tax reform tailwind help level play field nfp
competitor lead increas capital-expenditure increas capit expenditur
program next three year compani oper outpati
site care across urgent care free stand ed asc imag center plan
increas site well add inpati bed remain activ
 manag state pipelin remain activ
ebitda less chang corpor tax rate chang corpor interest incom longer subject us impact ni impact inc
hca recent acquisit repres revenu
continu increas return sharehold share repurchas
new dividend announc dividend first time also repurchas
mm share remain share repurchas author
facilitylocationbedscommenthouston northwest medic centerhouston houston areacypress fairbank medic center hospit houston houston areapark plaza hospitalhouston houston areatombal region medic centertombal houston areasouth texa region centerjourdanton san antonio areaweatherford region medic centerweatherford dalla ft worth areahighland region medic centersebr mile west ft piercesatilla region medic centerwaycross jacksonvil area facilitiesmemori hospit savannah level picu servic level trauma servic area inc
increas pt pt base multipl revis
ev/ebitda mm
pt contempl ev/ebitda ebitda view
factset compani report leerink partner llc research estim note mm except per share
trade consensu ev/ebitda
factset compani report leerink partner llc research estim note mm except per share
primari valuat methodolog base rel ev/ebitda rel
ev/ebitda track function compani histori hospit group averag
assess potenti ev/ebitda expans next month base forward
forecast contempl underli fundament implic healthcar reform
base rate outperform price target base
ev/ebitda ebitda view
downsid risk valuat includ
possibl delay medicaid expans current non-expans state
headlin risk gop effort repeal
downsid risk leverag
legisl regul cut govern commerci payer reimburs
price target base pro-forma ebitda leverag post transact
downsid risk valuat includ
possibl delay medicaid expans current non-expans state
delay time sale hospit asset initi improv physician
product expens reduct
headlin risk gop effort repeal
exposur larg earn swing result high leverag
variou on-going legal proceed may result cash outflow
primari valuat methodolog base rel ev/ebitda rel
ev/ebitda track function compani histori hospit group averag
assess potenti ev/ebitda expans next month base forward
forecast contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
point potenti multipl expans along sector compani specif
catalyst expect greater potenti multipl expans dcf valuat point
significantli upsid peer current trade level base rate
lpnt outperform price target base ev/ebitda
downsid risk valuat includ
possibl delay medicaid expans current non-expans state
headlin risk gop effort repeal alter two midnight rule
downsid risk leverag
legisl regul cut government commerci payer reimburs
rate outperform price target base combin enterpris
valu ebitda multipl valuat base forward forecast contempl underli
fundament implic sum-of-the-part valuat rang
downsid risk valuat includ
possibl delay medicaid expans current non-expans state
headlin risk gop effort repeal alter two midnight rule
downsid risk leverag
legisl regul cut government commerci payer reimburs
primari valuat methodolog base rel ev/ebitda rel
ev/ebitda track function compani histori hospit group averag
assess potenti ev/ebitda expans next month base forward
forecast contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
point potenti multipl expans along sector compani specif
catalyst expect greater potenti multipl expans dcf valuat point
significantli upsid peer current trade level base rate
outperform price target base ev/ebitda
downsid risk valuat includ
possibl delay medicaid expans current non-expans state
headlin risk gop effort repeal
acut care segment highli concentr la vega texa
lower expect near-term benefit econom tailwind
cut govern commerci payer reimburs
declin receiv collect rate
incom statement mm except provis doubt net expensessalari oper total oper depreci incom ebit net interest pbt incom tax incom yoy incom attribut non-controlling net incom attribut net incom attribut share dilut yoy dilut yoy growth growth expense/net opex/net debt/gross inc
